US$ 23.09
semaglutide package Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s Prescribing | Ozempic® (semaglutide) pill
Description
[PubMed] [Google Scholar] 56.Fehse F, Trautmann M, Holst JJ, et al

Novo Nordisk and the FDA have pushed back on the practice, warning that the off-brand drugs havent been evaluated for safety or effectiveness
The FDA provided a grace period for compounding pharmacies, allowing them until April 22, 2025 to stop production

While this can support weight loss, it also increases the risk of lean muscle loss if protein intake is too low
